JP Morgan Chase’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-2,500
Closed -$460K – 7709
2024
Q1
$460K Buy
+2,500
New +$476K ﹤0.01% 4872
2022
Q4
– Sell
-7,700
Closed -$1.44M – 6939
2022
Q3
$1.44M Buy
+7,700
New +$1.62M ﹤0.01% 3755

Other funds holding RGEN

JP Morgan Chase's RGEN Position: Q3 2026 in Review

JP Morgan Chase reduced its Repligen (RGEN) stake by 65% in Q3 2026, selling an estimated $45.6M and leaving 147,624 shares worth $29.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1901.

JP Morgan Chase first reported a position in RGEN in Q2 2014 and has held it in 46 quarters since. The position peaked at $98.2M in Q1 2021. 525 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • JP Morgan Chase held 147,624 shares of Repligen worth $29.3M as of Q3 2026.
  • JP Morgan Chase sold 280,146 Repligen shares in Q3 2026, an estimated $45.6M.
  • Repligen made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #1901 holding.
  • JP Morgan Chase first reported a position in Repligen in Q2 2014 and has held it in 46 quarters since.
  • JP Morgan Chase's Repligen position peaked at $98.2M in Q1 2021.
  • 525 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.